AI-powered colonoscopy device cleared for US market

The FDA has issued 510(k) clearance for a new artificial intelligence solution for colonoscopy screenings. 

Advertisement

The Magentiq-Colo, created by Israel-based technology company Magentiq-Eye, is one of the only AI-powered colonoscopy systems in the U.S., according to a July 31 news release from the company. 

Colorectal cancer is the third-leading cause of cancer related death in the U.S., and a missed polyp during a colonoscopy can lead to interval cancer, which accounts for 8 percent to 10 percent of all colorectal cancer cases in the U.S. 

In 2022, a 950-patient study cited by Magentiq-Colo found the device increased adenoma detection by 26 percent, which correlates to a 35 percent decrease in patient mortality, the release said.

Advertisement

Next Up in GI & Endoscopy

  • Renton, Wash.-based Providence has re-opened its North Coast Surgery Center in Oceanside, Calif., the Times Standard reported Feb. 5.  The…

  • Gastroenterology is rapidly transforming as health systems invest in outpatient digestive care, private equity-backed platforms expand and new technology reshapes…

  • AI’s early gains in gastroenterology are showing up in some of the most workflow-heavy parts of endoscopy — polyp detection,…

Advertisement

Comments are closed.